Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss.
Xie X, Cheng P, Hu L, Zhou W, Zhang D, Knoedler S, Liu G, Xiong Y, Xue H, Hu Y, Kern B, Obed D, Panayi AC, Chen L, Yan C, Lin Z, Dai G, Mi B, Zhang Y, Liu G.
Xie X, et al. Among authors: cheng p.
Signal Transduct Target Ther. 2024 Jan 22;9(1):24. doi: 10.1038/s41392-023-01726-8.
Signal Transduct Target Ther. 2024.
PMID: 38246920
Free PMC article.